Haemonetics: Fiscal Q1 Earnings Snapshot

August 10, 2022 GMT

BOSTON (AP) _ Haemonetics Corp. (HAE) on Wednesday reported fiscal first-quarter net income of $19.9 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Boston-based company said it had net income of 38 cents. Earnings, adjusted for non-recurring costs and restructuring costs, were 58 cents per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 53 cents per share.

The provider blood management systems for health care providers and blood collectors posted revenue of $261.5 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $251 million.

Haemonetics expects full-year earnings in the range of $2.50 to $2.90 per share.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE